ERBB2 and triple-negative breast carcinoma: Notably, basal-like and triple-negative breast cancers exhibit a high degree of gene expression profile overlap, with ∼80% of BLBCs being ER-negative and HER2-negative, and 50–75% of TNBCs displaying a basal-like phenotype [20,21,22] (reviewed in [23,24,25]).